The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine.
DOI: 10.1093/cid/ciab850; PMCID: PMC8522412
Determining the duration of immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is critical for informing the timing of booster immunization. Many genetic and environmental factors could influence both the magnitude and persistence of the antibody response. Here, we showed that SARS-CoV-2 infection before vaccination and age affected the decay of antibody responses to the SARS-CoV-2 messenger RNA vaccine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Antibodies, Viral; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccination; Vaccines, Synthetic; Viral Vaccines; mRNA Vaccines
19; 2; Antibody response; COVID; CoV; SARS; Vaccine
Fraley E, LeMaster C, Khanal S, et al. The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine. Clin Infect Dis. 2022;75(1):e902-e904. doi:10.1093/cid/ciab850